CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents 2-Year Clinical Outcomes: From the BIONICS and NIREUS Trials Position paper of the EACVI and EANM on artificial intelligence applications in multimodality cardiovascular imaging using SPECT/CT, PET/CT, and cardiac CT Successful catheter ablation of electrical storm after myocardial infarction Best Practices for the Prevention of Radial Artery Occlusion After Transradial Diagnostic Angiography and Intervention An International Consensus Paper ST-Segment Elevation Myocardial Infarction Patients in the Coronary Care Unit Is it Time to Break Old Habits? Cardiac Troponin Elevation in Patients Without a Specific Diagnosis The spectrum of chronic coronary syndromes: genetics, imaging, and management after PCI and CABG Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial Right ventricular stroke work correlates with outcomes in pediatric pulmonary arterial hypertension Mortality 10 Years After Percutaneous or Surgical Revascularization in Patients With Total Coronary Artery Occlusions

Original ResearchSeptember 2019

JOURNAL:JACC Cardiovasc Interv. Article Link

Physiologic Characteristics and Clinical Outcomes of Patients With Discordance Between FFR and iFR

SH Lee, KH Choi, JM Lee et al. Keywords: coronary artery disease; coronary flow reserve; fractional flow reserve; instantaneous wave-free ratio; prognosis

ABSTRACT


OBJECTIVES - The study evaluated the physiologic characteristics of discordant lesions between instantaneous wave-free ratio (iFR) and fractional flow reserve (FFR) and the prognosis at 5 years.

 

BACKGROUND - FFR or iFR have been standard methods for assessing the functional significance of coronary artery stenosis. However, limited data exist about the physiologic characteristics of discordant lesions and the prognostic implications resulting from these lesions.

 

METHODS - A total of 840 vessels from 596 patients were classified according to iFR and FFR; high iFRhigh FFR (n = 580), low iFRhigh FFR (n = 40), high iFRlow FFR (n = 69), and low iFRlow FFR (n = 128) groups, which were compared with a control group (n = 23). The differences in coronary circulatory indices including the coronary flow reserve (CFR), index of microcirculatory resistance (IMR), and resistance reserve ratio (RRR) (resting distal arterial pressure × mean transit time / hyperemic distal arterial pressure × hyperemic mean transit time), which reflect the vasodilatory capacity of coronary microcirculation, were compared. Patient-oriented composite outcomes (POCO) at 5 years including all-cause death, any myocardial infarction, and any revascularization were compared among patients with deferred lesions.

 

RESULTS- In the low iFRhigh FFR group, CFR, RRR, and IMR measurements were similar to the low iFRlow FFR group: CFR 2.71 versus 2.43 (p = 0.144), RRR 3.36 versus 3.68 (p = 0.241), and IMR 18.51 versus 17.38 (p = 0.476). In the high iFRlow FFR group, the CFR, RRR, and IMR measurements were similar to the control group: CFR 2.95 versus 3.29 (p = 0.160), RRR 4.28 versus 4.00 (p = 0.414), and IMR 17.44 versus 17.06 (p = 0.818). Among the 4 groups, classified by iFR and FFR, CFR and RRR were all significantly different, except for IMR. However, there were no significant differences in the rates of POCO, regardless of discordance between the iFR and FFR. Only the low iFRlow FFR group had a higher POCO rate compared with the high iFRhigh FFR group (adjusted hazard ratio: 2.46; 95% confidence interval: 1.17 to 5.16; p = 0.018).

 

CONCLUSIONS-  Differences in coronary circulatory function were found, especially in the vasodilatory capacity between the low iFRhigh FFR and high iFRlow FFR groups. FFRiFR discordance was not related to an increased risk of POCO among patients with deferred lesions at 5 years. (Clinical, Physiological and Prognostic Implication of Microvascular Status; NCT02186093; Physiologic Assessment of Microvascular Function in Heart Transplant Patients; NCT02798731)